¿¬¼ö°­ÁÂ
´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 3ÀÏÂ÷ : 2024-06-15

´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 3ÀÏÂ÷ : 2024-06-15
±³À°ÀÏÀÚ : 2024-06-15
±³À°Àå¼Ò : COEX, Seoul, Korea

±³À°ÁÖÁ¦ : APCN & KSN 2024 3ÀÏÂ÷

ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736  

À̸ÞÀÏ : ksn@ksn.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 27 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 250,000¿ø  

ºñ°í ¡áȸ¿ø: »çÀü(200,000)/ÇöÀå(250,000) ¡áºñȸ¿ø: »çÀü(250,000)/ ÇöÀå(250,000) ¡áPhysician in training/Nurse/Paramedics/Allied Health: »çÀü(100,000)/ ÇöÀå(125,000) *Student, ¸¸65¼¼ ÀÌ»ó ȸ¿ø: ¸éÁ¦


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 08:30~08:50 Insight into Glomerular Filtration and Albuminuria David J. Salant(Boston University School of Medicine)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 08:50~09:10 Complement Activation in Glomerular Diseases Nick Medjeral-Thomas(Hammersmith Hospital / Imperial College London)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 09:10~09:30 Target Antigens in Membranous Nephropathy Sanjeev Sethi(Mayo Clinic)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 09:30~09:50 Biobank-driven Multi-omics Analyses of Glomerular Diseases ±èµ¿±â(¼­¿ï´ëÇб³º´¿ø)

Åä·Ð 06¿ù 15ÀÏ Room 1 09:50~10:00 Q&A All Speaker()

ÈÞ½Ä 06¿ù 15ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 10:30~10:50 Histologic Classification of IgA Nephropathy: It's Role in Patient Care Ian S D Roberts(Oxford University Hospitals NHS Foundation Trust)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 10:50~11:10 Renal Pathology Associated with Monoclonal Gammopathy Su-Xia Wang(Peking University First Hospital)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 11:10~11:30 Glomerular Diseases with Nonamyloid Fibrillar Deposits Kelly D Smith(University of Washington)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 11:30~11:50 Digital Platform and Artificial Intelligence in Renal Pathology °íÇöÁ¤(¼­¿ï ¾Æ»êº´¿ø)

Åä·Ð 06¿ù 15ÀÏ Room 1 11:50~12:00 Q&A All Speaker()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 15:00~15:30 Home Versus Facility Dialysis and Mortality in Australia and New Zealand Mark R. Marshall(Middlemore Hospital)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 15:30~16:00 Changes in Insurance and Financial Support for Hemodialysis Patients in Japan: Focusing on Home Hemodialysis Ikuto Masakane(Yabuki Hospital)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 16:00~16:30 The Development History of Korean Mobile Hemodialysis Machines Jintae Lee(Synopex Inc.)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 17:00~17:20 Optimizing the PD Prescription for Improved Outcomes Adrian Liew(Mount Elizabeth Novena Hospital )

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 17:20~17:40 Training the PD Nurse for a Successful PD Program Josephine Chow(University of New South Wales)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 17:40~18:00 Continuous Quality Improvement in a PD Program Lily Mushahar(Hospital Tuanku Ja)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 1 18:00~18:20 Managing Non-Infectious Complications of Peritoneal Dialysis Rajnish Mehrotra(University of Washington School of Medicine)

Åä·Ð 06¿ù 15ÀÏ Room 1 18:20~18:30 Q&A All Speaker()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 08:30~08:50 Cardiovascular Risk Factors Associated with Kidney Disease Robert J. Walker(Otago Medical School University of Otago)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 08:50~09:10 Current and Future of Telemedicine and Telenephrology Masaomi Nangaku(The University of Tokyo Graduate School of Medicine)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 09:10~09:30 BP Control in Advanced CKD ÇѽÂÇõ(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 09:30~09:50 Optimizing Potassium Management for Cardio-kidney-metabolic Complications Angela Yee-Moon Wang(Queen Mary Hospital, The University of Hong Kong)

Åä·Ð 06¿ù 15ÀÏ Room 2 09:50~10:00 Q&A All Speaker()

ÈÞ½Ä 06¿ù 15ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 10:30~10:50 Pathophysiological Mechanisms Leading to Muscle Loss in Chronic Kidney Disease S. Russ Price(East Carolina University)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 10:50~11:10 Cachexia and Chronic Kidney Disease Kamyar Kalantar-Zadeh(Harbor-UCLA Medical Center)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 11:10~11:30 Promising Way to Mitigate Sarcopenia in CKD: Exercise ±èÁØö(CHA ÀÇ°ú´ëÇб³ºÎ¼Ó ±¸¹ÌÂ÷º´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 11:30~11:50 Reconciling Nutrition Support Supplementation with the Deeper Metabolic Picture of Muscle Wasting in Dialysis Patients - Understanding the Science of Nutrition Intervention Tilakavati Karupaiah(Taylor's University)

Åä·Ð 06¿ù 15ÀÏ Room 2 11:50~12:00 Q&A All Speaker()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 15:00~15:20 Management of Diabetes and CKD - Insights from the KDIGO 2022 Diabetes Guideline and ADA Consensus Report Peter Rossing(Steno Diabetes Center Copenhagen)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 15:20~15:40 Referral Time to Nephrology Care Á¤¼ºÁø(°¡Å縯´ëÇб³ ¿©Àǵµ¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 15:40~16:00 Implementation of the 2022 Diabetes Guideline: Progress and Barriers Juliana Chan(The Chinese University of Hong Kong)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 2 16:00~16:20 Story Not Covered in the Guideline Çѽ¼®(¼­¿ï´ëÇб³º´¿ø)

Åä·Ð 06¿ù 15ÀÏ Room 2 16:20~16:30 Q&A All Speaker()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 08:30~08:50 The Effects of Uremic Toxin on Heart Functions in HD Patients Hongli Lin(First Affiliated Hospital of Dalian Medical University)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 08:50~09:10 Hemodiafiltration and Expanded Hemodialysis: A Look Towards the Future Hideki Kawanishi(Tsuchiya General Hospital)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 09:10~09:30 Uremic Toxins and Clinical Outcomes in Hemodialysis I-Wen Wu(Keelung Chang Gung Memorial Hospital)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 09:30~09:50 Hemodialysis in the Elderly Patients: Practical Concerns and Considerations ±Ç¼øÈ¿(¼øõÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø)

Åä·Ð 06¿ù 15ÀÏ Room 3 09:50~10:00 Q&A All Speaker()

ÈÞ½Ä 06¿ù 15ÀÏ 10:00~10:20 Break ()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 10:20~10:40 How to Treat Renal Anemia in Peritoneal Dialysis Patients in Japan: Lessons from JSDT Data Analysis Takahiro Imaizumi(Nagoya University)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 10:40~11:00 How to Improve the Outcome of Peritoneal Dialysis? Salt Is a New Poison for PD Yasuhiko Ito(Aichi Medical University)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 11:00~11:20 Benefits of Remote Monitoring in PD: Review of Clinical Trials °í°­Áö(°í·Á´ëÇб³ ±¸·Îº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 11:20~11:40 Smart Peritoneal Dialysis Program for PD Quality Control Zhiming Ye(Guangdong Provincial People)

Åä·Ð 06¿ù 15ÀÏ Room 3 15:00~16:30 Oral Communications 9: Renal Conservative Care/Geriatrics Reshma Aziz Merchant, ¹Ú¹«¿ë(National University Health System, ¼øõÇâ´ëÇб³ ºÎõº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 17:00~17:20 How to Conquer Physiological and Clinical Fistula Immaturity Dirk M Hentschel(Harvard Medical School)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 17:20~17:40 Is HD Catheter a Necessary Evil? ±èµµÇü(ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 17:40~18:00 Challenges Faced in Setting up PTA Service by Interventional Nephrologists in a Developing Nation Vinoth Kasi Rajan(Queen Elizabeth Hospital)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 3 18:00~18:20 Implanting PD Catheter Exit-site Facing an Upward Direction Masato Ikeda(The Jikei University School of Medicine Katsushika Medical Center)

Åä·Ð 06¿ù 15ÀÏ Room 3 18:20~18:30 Q&A All Speaker()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 4 08:30~08:50 Blood Pressure Management in Elderly CKD Patients ¹èÀºÁø(â¿ø°æ»ó±¹¸³´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 4 08:50~09:10 Appropriate Use of Diuretics to Control Blood Pressure in CKD °íÀº½Ç(°¡Å縯´ëÇб³ ¿©Àǵµ¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 4 09:10~09:30 Resistant Hypertension in CKD Akihiro Nomura(Kanazawa University)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 4 09:30~09:50 Sympathetic Overactivity and Cardiovascular Morbidity in Dialysis Patients Robert J. Walker(Otago Medical School University of Otago)

Åä·Ð 06¿ù 15ÀÏ Room 4 09:50~10:00 Q&A All Speaker()

ÈÞ½Ä 06¿ù 15ÀÏ 10:00~10:20 Break ()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 4 10:30~10:50 When Do We Do Gene Tests in Children with Hematuria? Jun Oh(University Medical Center Hamburg-Eppendorf)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 4 10:50~11:10 Is Kidney Biopsy Necessary to Diagnose IgA Nephropathy in Children? ½ÅÀçÀÏ(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 4 11:10~11:30 When Do We Use Immunosuppression in Children with IgA Nephropathy? °­Èñ°æ(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 4 11:30~11:50 Do We Treat IgA Nephropathy and IgAV Differently? Dieter Haffner(Hannover Medical School)

Åä·Ð 06¿ù 15ÀÏ Room 4 11:50~12:00 Q&A All Speaker()

Åä·Ð 06¿ù 15ÀÏ Room 4 15:00~16:30 Oral Communications 10: Pediatrics/Genetics Á¶¹ÎÇö, Alison Ma(°æºÏ´ëÇб³º´¿ø, Hong Kong Children)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 08:30~08:50 Clinical Applications of Body Composition and Muscle Strength in CKD ¼Û¿µ¸²(ÇѸ²´ëÇб³ ¼º½Éº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 08:50~09:10 Muscle Energetics and Function in Kidney Disease Alp Ikizler(Vanderbilt University School of Medicine)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 09:10~09:30 The Sarcopenic Obesity Paradigm in CKD Csaba Kovesdy(University of Tennessee Health Science Center)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 09:30~09:50 Pathophysiology and Potential Treatment of Uremic Sarcopenia Chih-Kang Chiang(National Taiwan University Hospital)

Åä·Ð 06¿ù 15ÀÏ Room 5 09:50~10:00 Q&A All Speaker()

ÈÞ½Ä 06¿ù 15ÀÏ 10:00~10:20 Break ()

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 10:30~10:50 Use of Suboptimal Kidney Donors in Tx Henry Pleass(The University of Sydney)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 10:50~11:10 ABO Incompatible Kidney Transplantation in Asia Pacific Yoshihiko Watarai(Japanese Red Cross Aichi Medical Center, Nagoya Daini Hospital)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 11:10~11:30 Gender Disparity in Kidney Transplantation in Asia Pacific ±èÀ±¹Ì(ÀÎÁ¦´ëÇб³ ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 11:30~11:50 Development of an Equity Framework in Transplantation Camilla Nonterah(University of Richimond)

Åä·Ð 06¿ù 15ÀÏ Room 5 11:50~12:00 Q&A All Speaker()

Åä·Ð 06¿ù 15ÀÏ Room 5 15:00~16:30 Oral Communications 11: Chronical Kidney Disease 2 Robert J. Walker, ¼Û»óÇå(Otago Medical School University of Otago, ºÎ»ê´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 17:00~17:15 ¿ì¸®³ª¶ó Åõ¼® ȯÀÚ ¹ßº´·ü ¹× À¯º´·ü ¹ÝÅÂÇö(°¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 17:15~17:30 ¿ì¸®³ª¶ó Åõ¼® ȯÀÚÀÇ ÀÓ»óÀû Ư¡ À±ÇýÀº(°¡Å縯´ëÇб³ ÀÎõ¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 17:30~17:45 ¿ì¸®³ª¶ó Åõ¼® ȯÀÚÀÇ »ýÁ¸ ºÐ¼® ±èÅÂÈñ(ÀÎÁ¦´ëÇб³ ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 17:45~18:00 2024³â Àΰø½ÅÀå½Ç ÀÎÁõÆò°¡ º¸°í ±è¸í±Ô(°í·Á´ëÇб³ ¾È¾Ïº´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 18:00~18:15 º¹¸·Åõ¼® ÀçÅðü¸® ½Ã¹ü»ç¾÷ º¸°í ½ÅÈ£½Ä(°í½ÅÀÇ´ë º¹À½º´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Room 5 18:15~18:30 Green Nephrology ±è¼Ò¹Ì(µ¿±¹´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 15ÀÏ Auditorium 13:30~14:20 Plenary Lecture 3: Stem Cell-derived Human Kidney Tissue for Drug Development and Tissue Engineering Melissa Little(Murdoch Children's Research Institute)

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[Àü³²] 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-04-11

±³À°ÀÏÀÚ : 2024-04-11 ±³À°Àå¼Ò : ¿©¼ö ¿¢½ºÆ÷ ÄÁº¥¼Ç¼¾ÅÍ ¿¢½ºÆ÷Ȧ ±³À°ÁÖÁ¦ : 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 1ÀÏÂ÷ÁÖÃÖ±â°ü : ´ëÇѸ鿪ÇÐȸ ´ã´çÀÚ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,887 , ´ñ±Û¼ö : 0

[±¤ÁÖ] ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd day : 2024-04-26

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ±¤ÁÖ ±è´ëÁß ÄÁº¥¼Ç ¼¾ÅÍ ÄÁº£¼Ç Ȧ ¿Ü 8°÷ ±³À°ÁÖÁ¦ : ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd dayÁÖÃÖ±â°ü : ´ëÇѽŰæ¿Ü°ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,766 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,068 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,715 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä) : 2024-02-25

±³À°ÀÏÀÚ : 2024-02-25 ±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø º»°ü ÁöÇÏ 1Ãþ ±èÁ¾±â Ȧ ±³À°ÁÖÁ¦ : ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä)ÁÖÃÖ±â°ü : ¼­

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,137 , ´ñ±Û¼ö : 0